U.S. Wound Care Market - By Product (Advanced Wound Dressing (Foam, Alginate), Surgical Wound Care, Traditional Wound Care, Therapy Devices, Biologics), Application (Chronic, Acute), End use (Hospital, Specialty Clinic, Homecare) – Forecast, 2023-2032

U.S. Wound Care Market - By Product (Advanced Wound Dressing (Foam, Alginate), Surgical Wound Care, Traditional Wound Care, Therapy Devices, Biologics), Application (Chronic, Acute), End use (Hospital, Specialty Clinic, Homecare) – Forecast, 2023-2032

U.S. Wound Care Market Size

U.S. Wound Care Market size was valued at USD 8 billion in 2022 and is speculated to register over 14.5% CAGR from 2023 to 2032. Wound care dressings refer to material that is applied directly to a wound to facilitate the healing process and protect the injured area. The increasing incidence of burn injuries is one of the major factors driving the demand for wound care dressings.
 

For instance, according to the American Burn Association, an estimated 450,000 individuals are treated annually due to burns in the U.S. Furthermore, the growing prevalence of diabetes across the U.S. is a significant factor contributing to delayed wound healing. Moreover, in 2023, as per the Centers for Disease Control and Prevention (CDC), approximately 38.4 million people in the U.S. suffer from diabetes, which accounts for about 11.6% of the country’s population. Diabetic foot ulcers and pressure ulcers are a common complication and are a major cause of hospital admissions in people with diabetes. Thus, this growing prevalence of diabetes is anticipated to boost demand of wound care dressings.
 

COVID-19 Impact

The COVID-19 pandemic had a significant impact on the wound care market in the U.S. It caused disruptions to healthcare services, raised patient concerns about safety, caused problems in the supply chain, limited healthcare expenditures, and redirected resources towards COVID-19 research. As a result, the market had experienced a decline in procedures, which hampered its upward trajectory.
 

U.S. Wound Care Market Trends

The increasing prevalence of acute and chronic wounds is a significant concern in healthcare with its implications on the wound care market. These wounds can result from various causes including accidents, surgeries, chronic health conditions, and lifestyle factors. Chronic wounds, such as diabetic foot ulcers, venous leg ulcers, and pressure ulcers, are particularly common.
 

• In the U.S., for instance, it is estimated that there are over 6 million chronic wound cases annually. Furthermore, diabetes-related foot ulcers are a prime example of chronic wounds.
   
• Additionally, growing government initiatives towards trauma cases, developing healthcare infrastructure, and patient support programs will spur the adoption of wound care products, thus propelling U.S. market revenue growth.
   

U.S. Wound Care Market Analysis

The market by product is categorized into advanced wound dressing, surgical wound care, traditional wound care, wound therapy devices and wound care biologics. The advanced wound dressing segment garnered USD 2.3 billion revenue size in the year 2022.
 

• The segment's adaptability and efficacy in wound treatment are the primary factors driving the segment's dominance. Moreover, foam dressings have a high absorption capacity and are useful for controlling wound exudate, or fluid that oozes from a wound. They aid in preserving the moisture-rich environment surrounding the wound while avoiding excessive moisture accumulation, which may be harmful to the healing process.
   
• Additionally, foam dressings are soft, pliable, and cushioned, providing comfort to the patient. Therefore, the aforementioned factors are projected to stimulate segment expansion.

Based on application, the U.S. wound care market is segmented into chronic and acute wounds. The chronic wounds segment is further bifurcated into diabetic foot ulcers, pressure ulcers, venous leg ulcers, and other chronic wounds. The acute wounds are subdivided into surgical wounds, trauma wounds, and burns. This segment garnered USD 4.5 billion revenue size in the year 2022.
 

• Diabetic foot ulcers are commonly treated using moist wound dressings, which is estimated to account for USD 7.2 billion by 2032, because they benefit from a moist wound healing environment. These ulcers, which often occur in individuals with diabetes, can be slow to heal and prone to complications due to the underlying factors associated with diabetes.  
   
• Further, diabetic patients are at an increased risk of wound infections due to compromised immune function and poor circulation. Wound care dressings help create a barrier against external contaminants, reducing the risk of infection, thereby promoting segment progression.
   

Based on end-use, the U.S. wound care market is segmented into hospitals, specialty clinics, home care settings, and other end-users. The hospitals segment garnered USD 3 billion revenue size in the year 2022.
 

• Hospitals have wound care teams and specialized wound care nurses that are experienced in assessing, treating, and managing various types of wounds. They are knowledgeable about the latest wound care techniques and technologies.
   
• Further, hospitals typically have a wide range of advanced wound care products, including specialized dressings, negative pressure wound therapy, and other innovative wound management tools. This ensures that the most appropriate and effective dressing can be selected for each patient's unique requirement.

U.S. wound care market accounted for USD 8 billion revenue size in 2022 and is predicted to witness substantial market growth over the analysis timeline.
 

• The government's increased efforts to treat diabetes will hasten the growth of the sector. For example, the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health have collaborated on the National Diabetes Education Program (NDEP).
   
• By providing diabetes-related information to a variety of individuals in developing countries, faith-based organizations, ethnic minorities, community-based organizations, and healthcare providers, the National Diabetes information Program aims to lessen the burden of prediabetes.
   
• Moreover, the market demand will be supported by the significant emphasis on research and development as well as ongoing innovation in wound care.
   

U.S. Wound Care Market Share

The U.S. wound care industry is consolidated, with key players including, Smith & Nephew, B. Braun Melsungen AG, and others dominating the market space. These companies focus on ongoing product innovation, geographical expansion, and partnerships to secure substantial market share. For instance, in September 2021, Omeza announced that the U.S. FDA had approved its Omeza collagen matrix. This matrix is made of hydrolyzed fish collagen and is used to treat chronic wounds such as diabetic ulcers, surgical wounds, and partial and full-thickness wounds.
 

Some of the eminent market participants operating in the U.S. wound care industry include

• Smith & Nephew
• Molnlycke Health Care AB
• ConvaTec Group PLC
• Ethicon (Johnson & Johnson)
• Baxter International
• URGO Medical
• Coloplast Corp.
• Medtronic plc
• 3M Company
• Derma Sciences Inc. (Integra LifeSciences)
• Medline Industries
• Advancis Medical
• B. Braun Melsungen AG
   

U.S. Wound Care Industry News

• In June 2023, JeNaCell first offered the wound dressing epicite balance to the market. This dressing is ideal for pressure ulcers, diabetic foot ulcers, venous leg ulcers, arterial leg ulcers, and soft tissue lesions—chronic wounds with low to medium exudation. This strategic introduction aimed to diversify the company's offering and enhance its revenue.
   
• In January 2023, in the U.S., Convatec introduced the ConvaFoam. ConvaFoam is a line of sophisticated foam dressings made to satisfy the needs of healthcare providers and their patients. This product launch expanded the company's product portfolio, delivering a significant competitive edge to the company.
   

U.S. wound care market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2018 to 2032 for the following segments

Click here to Buy Section of this Report

By Product, 2018 – 2032 (USD Million)

• Advanced wound dressing 
  • Foam dressings
  • Hydrocolloid dressings
  • Film dressings
  • Alginate dressings
  • Hydrogel dressings
  • Collagen dressings
  • Other advanced dressings
• Surgical wound care 
  • Sutures & staples
  • Tissue adhesive and sealants
  • Anti-infective dressing
• Traditional wound care 
  • Medical tapes
  • Cotton
  • Bandages
  • Gauzes
  • Sponges
  • Cleansing agents
• Wound therapy devices 
  • Negative pressure wound therapy
  • Oxygen and hyperbaric oxygen equipment
  • Electric stimulation devices
  • Pressure relief devices
  • Other wound therapy devices
• Wound care biologics 
  • Skin substitutes
    • Biological
      • Allograft
      • Xenograft
      • Other biologicals
    • Synthetic 
  •  Topical agents

By Application, 2018 – 2032 (USD Million)

• Chronic wounds 
  • Diabetic foot ulcers
  • Pressure ulcers
  • Venous leg ulcers
  • Other chronic wounds
• Acute wounds 
  • Surgical wounds
  • Traumatic wounds
  • Burns

By End-use, 2018 – 2032 (USD Million)

• Hospitals
• Specialty clinics
• Home care settings
• Other end-users